Teruo Yamauchi

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Vitamin E δ-Tocotrienol Augments the Antitumor Activity of Gemcitabine and Suppresses Constitutive NF-κB Activation in Pancreatic Cancer

Kazim Husain, R François, Teruo Yamauchi et al. · Molecular Cancer Therapeutics · 2011 · 103 citations

Medicine, Oncology, Pharmacology +14

Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Akina Natori, Toru Ogata, Masahiko Sumitani et al. · Clinical Cancer Research · 2015 · 38 citations · Full text

Medicine, Neuroscience, Oncology +16

Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life

Mikiko Kaizu, Hiroko Komatsu, Hideko Yamauchi et al. · Supportive Care in Cancer · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

A self‐directed home yoga programme for women with breast cancer during chemotherapy: A feasibility study

Hiroko Komatsu, Kaori Yagasaki, Hideko Yamauchi et al. · International Journal of Nursing Practice · 2015 · 32 citations · Full text

Medicine, Oncology, Cancer Rehabilitation +16